Clinical and neurophysiologic assessment of strength and spasticity during intrathecal baclofen titration in incomplete spinal cord injury: Single-subject design

Journal of Spinal Cord Medicine

Volumn 32, Issue 2, 2009, Pages 183-190

  Bowden, Mark ^a   Stokic, Dobrivoje S ^b  

^a Brain Rehabilitation Research Center   (United States)

^b METHODIST REHABILITATION CENTER   (United States)

Author keywords

Baclofen; Hoffman reflex; Hypertonia; Intrathecal; Muscle strength; Paraplegia; Reflexes; Spasticity; Spinal cord injuries

Indexed keywords

BACLOFEN;

ADULT; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFECT; ELECTROMYOGRAM; ELECTRONEUROLOGY; HOFFMANN REFLEX; HUMAN; LEG; MALE; MEDICAL DECISION MAKING; MUSCLE CONTRACTION; MUSCLE STRENGTH; NEUROPHYSIOLOGY; SPASTICITY; SPINAL CORD INJURY; TRAFFIC ACCIDENT; TREATMENT OUTCOME; VOLUNTARY MOVEMENT; WITHDRAWAL REFLEX;

EID: 66449091251     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2009.11760770     Document Type: Article

References (43)

1. Priebe MM, Sherwood AM, Thornby JI, Kharas NF, Markowski J. Clinical assessment of spasticity in spinal cord injury: a multidimensional problem. Arch Phys Med Rehabil. 1996;77:713-716. (Pubitemid 26240519)
2. Lance JW. Spasticity: disordered motor control (Year Book). In: Feldman R, Young R, Koella W, eds. Symposium Synopsis. Chicago, IL: Medical Publishers; 1980:485-500.
3. Katz RT, Rymer WZ. Spastic hypertonia: mechanisms and measurement. Arch Phys Med Rehabil. 1989;70:144-155. (Pubitemid 19066478)
4. Skold C, Levi R, Seiger A. Spasticity after traumatic spinal cord injury: nature, severity, and location. Arch Phys Med Rehabil. 1999;80:1548-1557.
5. Abbruzzese G. The medical management of spasticity. Eur J Neurol. 2002;9(suppl 1):30-34.
6. Young RR. Treatment of spastic paresis. N Engl J Med. 1989;320:1553-1555. (Pubitemid 19145810)
7. Ivanhoe CB, Tilton AH, Francisco GE. Intrathecal baclofen therapy for spastic hypertonia. Phys Med Rehabil Clin North Am. 2001;12:923-938. (Pubitemid 33049655)
8. Francisco GE, Yablon SA, Schiess MC, Wiggs L, Cavalier S, Grissom S. Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia. Top Stroke Rehabil. 2006;13:74-85. (Pubitemid 44748621)
9. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540-542.
10. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67:206-207. (Pubitemid 17026064)
11. Thilmann AF, Fellows SJ, Garms E. The mechanism of spastic muscle hypertonus. Variation in reflex gain over the time course of spasticity. Brain. 1991;114:233-244.
12. Sinkjaer T, Magnussen I. Passive, intrinsic and reflexmediated stiffness in the ankle extensors of hemiparetic patients. Brain. 1994;117:355-363. (Pubitemid 24155507)
13. Abel NA, Smith RA. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehabil. 1994;75:54-58. (Pubitemid 24038826)
14. Ochs G, Struppler A, Meyerson BA, et al. Intrathecal baclofen for long-term treatment of spasticity: a multicentre study. J Neurol Neurosurg Psychiatry. 1989,52:933-939. (Pubitemid 19220164)
15. Lazorthes Y, Sallerin-Caute B, Verdie JC, Bastide R, Carillo JP. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg. 1990;72:393-402. (Pubitemid 20072962)
16. Azouvi P, Roby-Brami A, Biraben A, Thiebaut JB, Thurel C, Bussel B. Effect of intrathecal baclofen on the monosynaptic reflex in humans: evidence for a postsynaptic action. J Neurol Neurosurg Psychiatry. 1993;56:515-519. (Pubitemid 23171783)
17. Latash ML, Penn RD, Corcos DM, Gottlieb GL. Short-term effects of intrathecal baclofen in spasticity. Exp Neurol. 1989;103:165-172. (Pubitemid 19047245)
18. Macdonell RA, Talalla A, Swash M, Grundy D. Intrathecal baclofen and the H-reflex. J Neurol Neurosurg Psychiatry. 1989;52:1110-1112. (Pubitemid 19232795)
19. Garcia-Larrea L, Mauguière F. Electrophysiological assessment of nociception in normals and patients: the use of nociceptive reflexes. In: Rossini PM, Mauguière F, eds. New Trends and Advanced Techniques in Clinical Neurophysiology. New York: Elsevier Science Publishers; 1990:102-118.
20. Parise M, Garcia-Larrea L, Mertens P, Sindou M, Mauguiere F. Clinical use of polysynaptic flexion reflexes in the management of spasticity with intrathecal baclofen. Electroencephalogr Clin Neurophysiol. 1997;105:141-148. (Pubitemid 27230279)
21. Campbell S, Almeida G, Penn R, Corcos D. The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther. 1995;75:352-362.
22. Almeida GL, Campbell SK, Girolami GL, Penn RD, Corcos DM. Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen. Phys Ther. 1997;77:751-764. (Pubitemid 27342320)
23. Dones I, Servello D, Molteni F, Mariani G, Broggi G. A neurophysiological method for the evaluation of motor performance in spastic walking patients. Acta Neurochir Suppl (Wien). 1995;64:26-29.
24. Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet. 1984;1:1078. (Pubitemid 14148960)
25. Marino RJ, Barros T, Biering-Sorensen F, et al., ASIA Neurological Standards Committee. 2002. International Standards for neurological classification of spinal cord injury. J Spinal Cord Med. 2003;26(suppl 1):s50-s56.
26. Angel R, Hofmann W. The H reflex in normal,spastic and rigid subjects. Arch Neurol. 1963;8:591-596.
27. Dario A, Scamoni C, Bono G, Ghezzi A, Zaffaroni M. Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion. Funct Neurol. 2001;16:311-315. (Pubitemid 34130232)
28. Middel B, Kuipers-Upmeijer H, Bouma J, et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry. 1997;63:204-209. (Pubitemid 27388970)
29. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg. 1992;77:236-240.
30. Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry. 2004;75:1553-1557. (Pubitemid 39430606)
31. Stokic DS, Yablon SA, Hayes A, Vesovic-Potic V, Olivier J. Dose-response relationship between the H-reflex and continuous intrathecal baclofen administration for management of spasticity. Clin Neurophysiol. 2006;117:1283-1289. (Pubitemid 43825777)
32. Sallerin-Caute B, Lazorthes Y, Monsarrat B, Cros J, Bastide R. CSF baclofen levels after intrathecal administration in severe spasticity. Eur J Clin Pharmacol. 1991;40:363-365.
33. Yablon SA, Stokic DS. Neurophysiological evaluation of spastic hypertonia: implications for management of the patient with the intrathecal baclofen pump. Am J Phys Med Rehabil. 2004;83(suppl):s10-s18. (Pubitemid 39281264)
34. Stokic DS, Yablon SA. Neurophysiological basis and clinical applications of the H-reflex as an adjunct for evaluating response to intrathecal baclofen for spasticity. In: Sakas DE, Simpson BA, Krames ES, eds. Operative Neuromodulation. Vol.1: Functional Neuroprosthetic Surgery. Wien: Springer-Verlag; 2007:231-241.
35. Cairns K, Stein J. Motor function improvement following intrathecal baclofen pump placement in a patient with locked-in syndrome. Am J Phys Med Rehabil. 2002;81:307-309. (Pubitemid 34270024)
36. Hoogstraten MC, van der Ploeg RJ, vd Burg W, Vreeling A, van Marle S, Minderhoud JM. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients. Acta Neurol Scand. 1988;77:224-230.
37. Orsnes G, Crone C, Krarup C, Petersen N, Nielsen J. The effect of baclofen on the transmission in spinal pathways in spastic multiple sclerosis patients. Clin Neurophysiol. 2000;111:1372-1379. (Pubitemid 30445169)
38. Macefield G, Gandevia SC, Bigland-Ritchie B, Gorman RB, Burke DJ. The firing rates of human motoneurones voluntarily activated in the absence of muscle afferent feedback. J Physiol. 1993;471:429-443. (Pubitemid 23345588)
39. Knutsson E, Richards C. Different types of disturbed motor control in gait of hemiparetic patients. Brain. 1979;102:405-430. (Pubitemid 9161011)
40. Dewald JPA, Beer RF. Abnormal joint torque patterns in the paretic upper limb of subjects with hemiparesis. Muscle Nerve. 2001;24:273-283. (Pubitemid 32105824)
41. Sgouros S, Seri S. The effect of intrathecal baclofen on muscle co-contraction in children with spasticity of cerebral origin. Pediatr Neurosurg. 2002;37:225-230. (Pubitemid 36160163)
42. Backman CL, Harris SR, Chisholm JA, Monette AD. Single-subject research in rehabilitation: a review of studies using AB, withdrawal, multiple baseline, and alternating treatments designs. Arch Phys Med Rehabil. 1997;78:1145-1153. (Pubitemid 27431300)
43. Backman CL, Harris SR. Case studies, single-subject research, and N of 1 randomized trials: comparisons and contrasts. Am J Phys Med Rehabil. 1999;78:170-176. (Pubitemid 29135766)